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DOI 10.1016/j.devcel.2011.08.017SUMMARY toxic functions that cause progressive degeneration of the cere-Although expansion of CAG repeats in ATAXIN1
(ATXN1) causes Spinocerebellar ataxia type 1, the
functions of ATXN1 and ATAXIN1-Like (ATXN1L)
remain poorly understood. To investigate the func-
tion of these proteins, we generated and character-
ized Atxn1L/ and Atxn1/; Atxn1L/ mice.
Atxn1L/ mice have hydrocephalus, omphalocele,
and lung alveolarization defects. These phenotypes
are more penetrant and severe in Atxn1/;
Atxn1L/mice, suggesting that ATXN1 and ATXN1L
are functionally redundant. Uponpursuing themolec-
ular mechanism, we discovered that several Matrix
metalloproteinase (Mmp) genes are overexpressed
and that the transcriptional repressor Capicua (CIC)
is destabilized in Atxn1L/ lungs. Consistent with
this, Cic deficiency causes lung alveolarization
defect. Loss of either ATXN1L or CIC derepresses
Etv4, an activator forMmp genes, thereby mediating
MMP9 overexpression. These findings demonstrate
a critical role of ATXN1/ATXN1L-CIC complexes in
extracellular matrix (ECM) remodeling during devel-
opment and their potential roles in pathogenesis of
disorders affecting ECM remodeling.
INTRODUCTION
The abnormal expansion of a CAG-repeat encoding a polyglut-
amine (polyQ) tract in ATXN1 causes the neurodegenerative
disease spinocerebellar ataxia type 1 (SCA1) (Orr et al., 1993;
Banfi et al., 1994). The resulting mutant ATXN1 protein acquires746 Developmental Cell 21, 746–757, October 18, 2011 ª2011 Elsevbellum, brainstem, and spinocerebellar tracts (Zoghbi and Orr,
1995). Because ATXN1 was identified as the gene causing
SCA1, the majority of studies on ATXN1 have been focused on
uncovering the molecular mechanisms underlying the neurotox-
icity of the mutant form of the protein. However, the function of
wild-type ATXN1 remains unclear. In an effort to understand
the in vivo function of ATXN1, we previously generated Atxn1
null mice (Matilla et al., 1998). These mice display deficits in
spatial and motor learning, but are otherwise viable and fertile
with no discernible defects in other tissues (Matilla et al.,
1998), suggesting that ATXN1 may not be essential for normal
development of peripheral tissues.
A mammalian paralog of ATXN1 was identified and named as
ATAXIN1-Like (ATXN1L) (also called Brother of ATXN1, BOAT)
(Bowman et al., 2007; Mizutani et al., 2005). ATXN1 and ATXN1L
share two highly conserved domains, one in the amino terminal
region and the other in the carboxyl terminal region termed
ATAXIN1 and HMG-box protein1 (AXH) domain (Mizutani et al.,
2005), respectively. They are expressed ubiquitously and their
tissue distributions are very similar (Mizutani et al., 2005), sug-
gesting that they may be functionally redundant.
To date, most of the clues about the potential functions of
these two proteins stem from knowledge of their interactors.
ATXN1 and ATXN1L share many common binding partners,
including Capicua (CIC), silencing mediator of retinoid and
thyroid hormone receptors (SMRT) and histone deacetylase 3
(HDAC3) (Mizutani et al., 2005; Lam et al., 2006; Lim et al.,
2006). Among the interactors, CIC is of particular interest,
because so far it is the only binding partner whose protein levels
are significantly reduced inAtxn1 null mice (Lamet al., 2006). CIC
is an HMGbox-containing DNA-binding protein that is evolution-
arily conserved from Caenorhabditis elegans to human (Jime´nez
et al., 2000), and functions as a transcriptional repressor by pref-
erential binding to TGAATGA/GA sequences in Drosophila andier Inc.
Table 1. Viability and Incidence for Gut Loss (at P0) and Omphalocele (at E18.5–E19) Per Each Genotype
Genotype
Observed (Expecteda) at P21
on Mixed Background
Observed (Expected) at P0
on C57BL/6 Background
Omphalocele
at E18.5–E19 Gut Loss at P0
Atxn1+/+; Atxn1L+/+ 8 (8) 15 (11.125) 0/5 0/15
Atxn1+/; Atxn1L+/+ 20 (23) 21 (22.25) 0/5 0/21
Atxn1/; Atxn1L+/+ 28 (19) 17 (11.125) 0/10 0/17
Atxn1+/+; Atxn1L+/ 12 (14) 21 (22.25) 0/10 0/21
Atxn1+/+; Atxn1L/ 5 (5) 18 (11.125) 0/6 1/18
Atxn1+/; Atxn1L+/ 54 (41) 39 (44.5) 0/31 0/39
Atxn1/; Atxn1L+/ 41 (35) 17 (22.25) 0/9 2/17
Atxn1+/; Atxn1L/ 11 (19) 19 (22.25) 2/11 3/19
Atxn1/; Atxn1L/ 0 (15) 11 (11.125) 5/11 5/11
Total 179 178 7/98 11/178
a The number of animals expected to be observed based on Mendelian genetics.
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Role of ATXN1 and ATXN1L in ECM Remodelingmammals (Ajuria et al., 2011; Kawamura-Saito et al., 2006). In
Drosophila, CIC functions downstream of receptor tyrosine
kinase (RTK) pathways including Torso, EGFR, Ras, Raf, and
mitogen-associated protein kinases (MAPKs) to mediate specifi-
cation of intervein areas in the wing, correct development of the
head and tail, and dorsoventral patterning (Jime´nez et al., 2000;
Roch et al., 2002). In mammalian HEK293 and melanoma cells,
MAPK signaling results in phosphorylation of CIC and subse-
quent loss of CIC-mediated transcriptional repression of PEA3
group genes (Dissanayake et al., 2011).
CIC exists in a large protein complex of 2 MDa in size
together with ATXN1 and ATXN1L in mouse cerebellum
(Bowman et al., 2007; Lam et al., 2006). Both ATXN1 and
ATXN1L bind to CIC and compete with each other for its binding
(Bowman et al., 2007). In cerebella from Atxn1 null mice, CIC
protein levels are decreased but mRNA levels are not changed,
suggesting that ATXN1 stabilizes CIC through protein-protein
interactions (Lam et al., 2006). Moreover, both ATXN1 and
ATXN1L can enhance the transcriptional repressor activity of
CIC in vitro (Lam et al., 2006; Crespo-Barreto et al., 2010), sug-
gesting that some endogenous functions of the ATXN1 protein
family must occur in cooperation with CIC.
Given that deletion of Atxn1 in mice yielded subtle learning and
memoryphenotypesbut no insight into thecellular functionsof this
protein (Matilla et al., 1998), we hypothesized that ATXN1 and
ATXN1L functionally substitute for each other and that we would
needdoublemutantmice tounderstand theendogenous functions
of the ATXN1 protein family. To this end, we generated Atxn1L/
mice and characterized the phenotypes of either Atxn1L/ or
Atxn1/; Atxn1L/ mice. We discovered that loss of ATXN1L
destabilizes CIC and affects postnatal viability; that ATXN1 and
ATXN1L are functionally redundant, as evident by the develop-
mental defects and perinatal lethality of the double null mice; and
that the ATXN1 protein family, together with CIC, regulates extra-
cellular matrix (ECM) remodeling during development.
RESULTS
ATXN1L Is Critical for Viability
We generated Atxn1L knockout mice using homologous recom-
bination to target the gene in embryonic stem cells (Figure S1ADevelopmavailable online). This strategy abolished the expression of
ATXN1L (Figure S1B). In a mixed 129S6/SvEv and C57BL/6J
background, all of the double null mice died before weaning
age (P21) (Table 1). Interestingly, about 40% of Atxn1+/;
Atxn1L/ mice also died before P21, whereas Atxn1/;
Atxn1L+/ mice were viable at the weaning age, suggesting
that Atxn1L is more crucial than Atxn1 for viability (Table 1).
When we backcrossed Atxn1L mutant mice to an almost pure
C57BL/6J background (more than 7 generations), we found
thatAtxn1L/micewere smaller than their littermates (Figure 1A
and Figure S1C) and that 50% of them died before P21 (Table
S1). Moreover, about 31% of the surviving Atxn1L/ animals
developed hydrocephalus (Figure 1B). Symptomatic Atxn1L/
mice developed a dome-shaped head, kyphosis, lethargy, and
emaciation sometime between 1 and 4 weeks after birth (data
not shown). In addition, Atxn1L+/ animals developed hydro-
cephalus at a very low frequency (<1%) (Figure 1B). Deficiency
of Atxn1L thus results in growth retardation, hydrocephalus,
and perinatal lethality on a C57BL/6J background.
Given the perinatal lethality of the Atxn1/; Atxn1L/ mice,
we tried to determine if loss of these two proteins causes embry-
onic lethality. Of the 178 newborn pups from Atxn1+/; Atxn1L+/
intercrosses, we observed 11 double null pups. This was consis-
tent with the expected Mendelian ratio (1 in 16), indicating that
loss of ATXN1 and ATXN1L does not cause embryonic lethality
(Table 1). However, about 73% (8/11) of the double null pups
were cyanotic (Figure 1C) and died within 3 hr after birth. This
early lethality was also found in Atxn1+/; Atxn1L/, Atxn1/;
Atxn1L+/, and even in Atxn1L/ animals, with lower ratios
(less than 20%; data not shown).
To investigate the cause of lethality in the double null mice,
we analyzed neonates and E18.5–E19 embryos by anatomical
and histological approaches. Given the hydrocephalus in
Atxn1L/ mice, we checked brain morphology and found that
the third and lateral ventricles were enlarged in 75% (3/4) of
the double null mice at birth, whereas 30% (3/10) of Atxn1+/;
Atxn1L/ and about 11% (1/9) of Atxn1L/ neonates had
this symptom (Figure 1D and Table 2). We also observed an om-
phalocele (umbilical hernia), a mild type of abdominal wall
closure defect, in about 45% of the double null embryos, and
to a lesser degree in Atxn1+/; Atxn1L/ embryos (Figure 1Eental Cell 21, 746–757, October 18, 2011 ª2011 Elsevier Inc. 747
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Figure 1. Developmental Abnormalities in Atxn1 and Atxn1L Double Mutant Mice
(A) Bar graph representation of the average body weight of Atxn1L/ and littermates at 3.5 weeks after birth. *p < 0.05. Error bars show standard deviation (SD).
(B) Incidence of hydrocephalus in Atxn1L/ mutants after weaning age. Right panel shows hematoxylin and eosin (H&E) staining of formalin-fixed section of
whole brains from hydrocephalic Atxn1L null mouse and WT littermate at 9 weeks after birth.
(C) Picture of Atxn1/; Atxn1L/ and wild-type neonates.
(D) Hydrocephalus inAtxn1/; Atxn1L/mice. H&E staining of formalin-fixed section of whole brains from hydrocephalicAtxn1/; Atxn1L/ andWT littermate
at P0.
(E) Abdominal wall closure defect inAtxn1/; Atxn1L/mice. Upper panel: images showing the abdominal wall closure defect in theAtxn1/; Atxn1L/ at E19.
The arrow indicates protruding gut into the umbilical ring (omphalocele). Middle panel: Abdominal anatomy on WT and Atxn1/; Atxn1L/ neonates. Arrow
indicates the midgut. Lower panel: shows the remaining guts dissected from WT and the Atxn1/; Atxn1L/ neonates.
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Role of ATXN1 and ATXN1L in ECM Remodelingand Table 1). It is known that an omphalocele results in the loss
of internal organs, such as gut and liver, because the mother
cannibalizes organs protruding into the umbilical ring in the
process of removing the placenta after birth (Thumkeo et al.,
2005). Anatomical analysis of organogenesis in the newborn748 Developmental Cell 21, 746–757, October 18, 2011 ª2011 Elsevpups revealed that about 45% of the double null pups lost the
midgut region from the small intestine to the cecum after birth
(Figure 1E and Table 1). The frequency of omphaloceles
and gut loss was higher in Atxn1+/; Atxn1L/ animals (17%)
than in Atxn1/; Atxn1L+/ animals (8%), and these defectsier Inc.
Table 2. Incidence for the Onset of Three Phenotypes in WT,
Atxn1–/–, Atxn1L–/–, Atxn1+/–; Atxn1L–/–, and Atxn1–/–; Atxn1L–/–
Mice
Genotype
Hydrocephalus %
(at P0)
Omphalocele %
(at E18.5–P0)
Lung
Alveolarization
Defect %
(at P17–P23)
Atxn1+/+;
Atxn1L+/+
0 (0/8) 0 (0/20) 0 (0/33)
Atxn1/;
Atxn1L+/+
0 (0/10) 0 (0/27) 0 (0/13)
Atxn1+/+;
Atxn1L/
11 (1/9) 4 (1/24) 65 (13/20)
Atxn1+/;
Atxn1L/
30 (3/10) 17 (5/30) 100 (2/2)a
Atxn1/;
Atxn1L/
75 (3/4) 45 (10/22) ND
ND, not determined.
a A majority of Atxn1+/; Atxn1L/ mice died before weaning age (P21)
on C57BL/6J background. Only two survivors were subjected to the anal-
ysis for the lung alveolarization.
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Role of ATXN1 and ATXN1L in ECM Remodelingwere sometimes observed in Atxn1L/ (4%), but not in
Atxn1/ animals (Tables 1 and 2). Collectively, these data
suggest that ATXN1L plays a more important role than ATXN1
for viability.
Alveolarization Defects in Atxn1L–/– Mice
Histological analysis of Atxn1/; Atxn1L/ neonates and
E17.5–E18.5 embryos revealed no abnormalities in most major
organs. However, we found that the double null embryos had
a lower proportion of empty space, representing saccules or ca-
naliculi, in lung sections in comparisonwith double heterozygous
littermates (Figures S2A and S2B). This finding suggested that
lung development may be abnormal in the double null embryos.
Mouse lung development proceeds in five distinct stages:
primary budding (E9.5–E11.5), pseudoglandular (E11.5–E16.5),
canalicular (E16.5–E17.5), saccular (E17.5–P5), and alveolar
(P5–P30) stages (Shi et al., 2007; Greenlee et al., 2007). Given
that defects in saccular development and septation at embry-
onic stages eventually lead to alveolarization defects at post-
natal stages (Oblander et al., 2005), we assessed lung
morphology in wild-type (WT), Atxn1/, and Atxn1L/ mice
at both early (P6) and late (P17–P23) alveolar stages. Histological
analysis of lungs showed that lung morphology was comparable
among the three different genotypes at P6, whereas alveolariza-
tion defects causing air space enlargement were apparent in
65% (13/20) of Atxn1L/ mice at late alveolar stage (P17–P23)
(Figure 2A and Table 2). Neither Atxn1/ (0/13) nor wild-type
mice (0/33) displayed defective alveolarization at this time point
(Figure 2A and Table 2). Furthermore, the alveolarization defect
was more severe in Atxn1+/; Atxn1L/ mice compared with
Atxn1L/ mice, suggesting that ATXN1 partially compensates
for loss of ATXN1L function (Figures S2C and S2D). Early peri-
natal lethality precluded an analysis of lung alveolarization in
the double null mice (Table 2). We also assessed epithelial cell
formation in lung tissues by hematoxylin and eosin (H&E) stain-
ing and immunohistochemistry for lung epithelial cell specificDevelopmmarkers (Clara cell secretory protein [CCSP] for Clara cells and
surfactant protein C [SFTPC] for type II lung epithelial cells) (Liu
et al., 2003) and found that the lung epithelia form normally in
Atxn1L/ mice at both early and late alveolar stages
(Figure S3A).
To elucidate the molecular mechanism mediating the alveola-
rization defect, we carried out microarray analyses using lung
total RNA from WT, Atxn1/, and Atxn1L/ mice at P6,
a time point prior to the manifestation of alveolarization defects.
We found a total of 406 gene expression alterations (328 upregu-
lated and 78 downregulated) with a fold change > 1.2 (p value <
0.05) in Atxn1L/ lung tissues (Table S2B), whereas only 54
genes (42 upregulated and 12 downregulated) were altered in
Atxn1/ lungs (Table S2A). Eighteen genes are shared among
the differentially expressed genes (DEGs) in Atxn1/ and
Atxn1L/ lungs, and about 72% of them (13 of 18) have a higher
fold change in Atxn1L/ mice compared to Atxn1/ mice
(Table S2C). Overall, these data suggest that the regulation of
gene expression relies more on ATXN1L rather than ATXN1 in
lungs at P6. To examine whether particular gene classes were
enriched among the DEGs in Atxn1L null lung tissue, we
analyzed the DEGs for gene ontology (GO) terms related to
cellular component using DAVID software (Dennis et al., 2003).
We found that the GO terms related to cell surface, plasma
membrane and extracellular region were significantly highly
ranked among the top 10 categories (Table S2D), suggesting
that compositions of the external area of cells might be altered
in Atxn1L/ lungs. Specifically, we found one set of genes
whose expression changes may be directly responsible for the
phenotypes of Atxn1 and Atxn1L double mutants. Matrix
metalloproteinase (Mmp) genes, the critical players in ECM re-
modeling, were upregulated in lung tissue from Atxn1L/ mice
(Table S2B). Either the overexpression of MMP9 in alveolar
macrophages, the induction of MMP12 expression in lung
epithelial cells or the loss of tissue inhibitor of metalloproteinase
3 (Timp3) causes air space enlargement in mouse lungs (Foronjy
et al., 2008; Qu et al., 2009; Leco et al., 2001), a prominent
phenotype in mice lacking Atxn1L. It is also noteworthy that
alterations in MMP levels and ECM formation are closely associ-
ated with pathogenesis of hydrocephalus and abdominal wall
hernias (Wyss-Coray et al., 1995; Zechel et al., 2002; Antoniou
et al., 2009; Suzuki et al., 1996), both highly penetrant in
Atxn1L-null mice. Therefore, we set out to confirm the Mmp
gene expression changes observed by transcriptional profiling
using qRT-PCR. Among eight Mmp genes, we found that
Mmp8,Mmp9,Mmp12, andMmp13 levels were significantly up-
regulated in Atxn1L/ lung tissues obtained from an indepen-
dent cohort of animals, consistent with the microarray results
(Figure 2B and Table S2B). However, also consistent with themi-
croarray results (Table S2A), the levels of most Mmp genes,
except for Mmp12 (p value = 0.0542), were not significantly
changed in Atxn1/ lung tissues, suggesting that increased
levels of multiple Mmp genes may be related with the alveolari-
zation defect in Atxn1L/ mice (Figure 2B). We confirmed the
overexpression of MMP9 proteins in lung and meningeal tissues
from Atxn1L/ mice compared with their WT littermates
(Figure 2C).
Given that alveolar macrophages are the major source for
secretion of MMP9 and MMP12 in lungs (Greenlee et al.,ental Cell 21, 746–757, October 18, 2011 ª2011 Elsevier Inc. 749
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Figure 2. Alveolarization Defects in
Atxn1L–/– Mice
(A) H&E staining of formalin-fixed section of lung
tissues fromWT,Atxn1/, and Atxn1L/ at either
P6 or P17. The alveolarization defect causing
enlargement of the air spaces is observed in
Atxn1L/ mice at P17.
(B) QRT-PCR analysis of levels of eight Mmp
genes using total RNA from the lungs of either WT,
Atxn1/, or Atxn1L/ at P6 (n = 4 per each
genotype). *p < 0.05. #p = 0.0542. All error bars
show SEM.
(C) Gelatin zymography and western blot analysis
showing increased MMP9 levels in lung and
meningeal tissues from 6-day-old Atxn1L/mice.
Twenty micrograms of lung extract and 10 mg of
meningeal tissue extract were loaded in each lane.
(D) QRT-PCR analysis for Timp1, Timp2, and
Timp3 levels in the lungs from 6-day-old wild-type
and Atxn1L/ mice (n = 3 per each genotype). All
error bars show SEM.
(E) Verhoeff staining for elastin of alveolar walls.
Formalin-fixed section of lung tissues from 7- to
9-month-old WT and Atxn1L/ mice was used.
Marked decrease in elastic fiber formation on
alveolar walls is found in Atxn1L/ mice with the
alveolarization defects, compared with WT. The
upper pictures show 103 magnified images for
Verhoeff staining. The lower pictures represent
enlarged images (803) for the boxed areas in the
upper pictures. Arrows indicate elastic fibers.
(F) Bar graph for quantification of percentage of
elastic fibril positive areawithin alveolar walls (n = 4
per each genotype). *p < 0.05. All error bars
show SEM.
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Role of ATXN1 and ATXN1L in ECM Remodeling2007), we investigated whether the number of alveolar macro-
phages is increased in Atxn1L/ mice compared with WT
mice. We counted the number of alveolar macrophage cells
in bronchoalveolar lavage fluid (BALF) and found that there is
no difference in the alveolar macrophage cell numbers
between WT and Atxn1L/ mice (Figure S3B), suggesting
that upregulation of a subset of Mmp gene levels in Atxn1L/
mice is not simply due to increase in the number of macro-
phage cells in lungs. Given that TIMPs are physiological inhib-
itors for MMPs, we checked whether levels of Timp genes are
changed in Atxn1L/ mice. Microarray and qRT-PCR anal-
yses showed that the levels of Timp genes were not signifi-
cantly changed in lungs from Atxn1L/ mice (Figure 2D and
Table S2B).750 Developmental Cell 21, 746–757, October 18, 2011 ª2011 Elsevier Inc.We further assessed the integrity of
ECM formation in Atxn1L/ lung tissues
by Verhoeff staining for elastin to investi-
gate whether the overexpression of
MMPs indeed affects ECM formation in
Atxn1L/ mice. Reduction in the area
occupied by elastic fibrils within the
alveolar walls was evident in symptom-
atic 7- to 9-month-old Atxn1L/ mice
compared with WT mice (Figures 2E and
2F). These data suggest that loss ofATXN1L causes the alveolarization defects associated with the
overexpression of MMPs and the decrease in elastic fiber forma-
tion in the lungs.
Loss of ATXN1/ATXN1L-Capicua Complexes Causes
the Lung Alveolarization Defect
To gain further insight into the molecular mechanism underlying
the phenotypes and the overexpression of a subset of Mmp
genes in the mutant animals, we focused on a common interac-
tor of ATXN1 and ATXN1L. Both ATXN1 and ATXN1L bind the
transcriptional repressor CIC to form endogenous protein
complexes in mouse cerebella (Bowman et al., 2007; Lim
et al., 2006). Coexpression of either ATXN1 or ATXN1L with
CIC synergistically enhanced the transcriptional repressor
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Figure 3. Loss of ATXN1/ATXN1L-CIC Complexes
Causes the Alveolarization Defects
(A) Western blot analysis for ATXN1, ATXN1L, and CIC
using several different tissues from E18.5 wild-type
embryos. Twenty micrograms of protein were loaded in
each lane.
(B) Representative western blot image showing the CIC
levels in lung and brain tissues from each genotype at
E18.5.
(C) Quantitative analysis of the CIC levels in the lung from
each genotype at E18.5 (n = 3 per each genotype). *p <
0.05. All error bars show SEM.
(D) Representative western blot image showing the CIC
levels in lung tissues from each genotype at P6.
(E) Quantitative analysis of the CIC levels in the lung
tissues from each genotype at P6 (n = 3 per each geno-
type). **p < 0.01. All error bars show SEM.
(F) Western blot image showing increased MMP9 levels in
lung tissues from Cic-L/ compared with Cic-L+/ mice.
(G) H&E staining of formalin-fixed lung tissues from the
Cic-L/ and Cic-L+/ mice at P20. Severe alveolarization
defects are observed in Cic-L/ mice.
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Role of ATXN1 and ATXN1L in ECM Remodelingactivity of CIC in vitro (Lam et al., 2006; Crespo-Barreto et al.,
2010), suggesting that ATXN1/ATXN1L and CIC could coopera-
tively function to regulate expression of CIC target genes. To
investigate whether this functional relationship between
ATXN1/ATXN1L and CIC is conserved in other peripheral tissues
or restricted only in brain, we checked expression profiles of
ATXN1, ATXN1L, andCIC in various tissues fromE18.5 embryos.
We found that their expression patterns were very similar, sug-
gesting that ATXN1/ATXN1L and CIC might function together
in peripheral tissues during embryogenesis (Figure 3A). Previous
work revealed that loss of ATXN1 reduces levels of CIC protein,
without change in Cic mRNA levels, in adult mouse cerebella
(Lam et al., 2006). Accordingly, we checked CIC levels in brain
and lung tissues from E18.5 embryos of five different genotypes.Developmental Cell 21, 74We found that both ATXN1 and ATXN1L are
required for maintaining the steady state level
of CIC but that CIC levels are more dramatically
decreased in Atxn1+/; Atxn1L/ than in
Atxn1/; Atxn1L+/ mice, suggesting that
ATXN1L plays a critical role for stabilizing CIC
during embryogenesis (Figures 3B and 3C).
The predominant role of ATXN1L for CIC stabili-
zation was also observed in lung tissue during
postnatal stages. Reduced levels of CIC protein
were more apparent in Atxn1L/ mice
compared with Atxn1/ mice at P6 (Figures
3D and 3E), whereas Cic mRNA levels were
not significantly changed in Atxn1L/ mice
(data not shown).
Given the critical roles of ATXN1L in both the
phenotypes found in mutant animals and the
stabilization of CIC, we hypothesized that
the phenotypes might be related to reduced
CIC levels. Recently, we generated Cic mutant
(Cic-L/) mice using ES cells in which the Cic
gene is targeted by a b-geo genetrap cassette
(Baygenomics). The expression of the longerformofCIC (CIC-L) iscompletelyabolished in thesemice,whereas
about 15%of the short formof CIC (CIC-S) is still expressed in the
cerebella (J.D.F. and H.Y.Z., unpublished data). The majority of
Cic-L/ mice died before weaning age (P21), and some of the
survivors were smaller than their littermates on the C57BL/6J
background (J.D.F. and H.Y.Z., unpublished data). To test the
hypothesis that CIC deficiency causes alveolarization defects
comparable to thedefects found inAtxn1Lnullmice,weexamined
the lung morphology and MMP9 levels in the Cic-L/ survivors.
The Cic-L/ mice indeed have increased levels of MMP9 and
severe alveolarization defects, compared with Cic-L+/ mice
(Figures 3F and 3G). These data suggest that the lung alveolariza-
tion defect in Atxn1 and Atxn1L doublemutant mice are likely due
to deficiency of ATXN1/ATXN1L-CIC complexes.6–757, October 18, 2011 ª2011 Elsevier Inc. 751
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Figure 4. Derepression of Pea3 Group
Genes by the Loss of ATXN1 and ATXN1L
(A) Schematic diagram for the location of CIC
binding sites (blue arrow head: TGAATGAA; red
arrow head: TGAATGGA) in Pea3 group gene
promoter regions. Black arrows indicate primers
designed to amplify Pea3 group gene promoter
regions containing CIC binding sites by PCR.
Transcription start site (+1) of each gene was
determined based on the following NCBI reference
sequences (NM_007960.4 for Etv1, NM_008815.2
for Etv4, and NM_023794.2 for Etv5).
(B) ChIP-PCR analysis showing CIC promoter
occupancy of Pea3 group genes in P6 lung tissue.
(C) QRT-PCR analysis of Etv1, Etv4, and Etv5
expression levels using total RNA from the lungs of
WT, Atxn1/, and Atxn1L/ mice (P6, n = 4 per
each genotype). *p < 0.05. All error bars
show SEM.
(D) Western blot image showing an increase in
ETV4 protein levels in lung tissues from Atxn1L/
mice. In contrast, ETV4 protein levels are normal in
Atxn1/ mice.
(E) QRT-PCR analysis of levels of Etv1, Etv4, and
Etv5 using total RNA from the lungs of embryos of
each genotype (E18.5, n = 4 per each genotype).
*p < 0.05 and **p < 0.01. All error bars show SEM.
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Role of ATXN1 and ATXN1L in ECM RemodelingDerepression of Pea3 Group Genes in Mutant Mice
Given the possibility that deficiency of ATXN1/ATXN1L-CIC
complexes is responsible for the alveolarization defect, we
turned our attention to the CIC target genes that may contribute
to the alteration of Mmp gene expression in Atxn1L/ mice.
Among the significantly upregulated genes (fold increase > 1.2,
p value < 0.05) in Atxn1L/ lung tissues, we searched for CIC
binding motifs (TGAATGA/GA) within a 1 kb region upstream
from the transcriptional start site. We also considered conserva-
tion scores of the 30 vertebrate species from the phastCons
track of the UCSC Genome Browser (http://genome.ucsc.edu/)
(Siepel et al., 2005). We discovered that four genes, Etv4 (also
known as Pea3), Prkcb, Nfkbie, and Runx3, had between one
to four CIC binding motifs and were significantly upregulated
by 1.2- to 1.4-fold (p value < 0.01) (Table S2B). Among these
genes, Etv4 got our attention, not only because it has the highest
fold increase and significance (Table S2B), but also because it752 Developmental Cell 21, 746–757, October 18, 2011 ª2011 Elsevier Inc.is known as a transcriptional activator for
many different types ofMMP genes (Gum
et al., 1996; Yan and Boyd, 2007). More-
over, more than one purine rich PEA3
element (A/CGGAA/T) exists in promoter
regions (within 5 kb upstream from the
transcription start site) of most mouse
Mmp genes (Table S3). ETV4 is one of
the members in PEA3 group transcription
factors, which include ETV1/ER81 and
ETV5/ERM. All Pea3 group members
have at least one CIC bindingmotif in their
promoter regions (Figure 4A). Notably,
previous studies have also verified that
their expression is regulated by CIC (Ka-wamura-Saito et al., 2006; Dissanayake et al., 2011). To examine
the possibility that expression of Pea3 group genes could be
regulated by CIC in lung, we investigated CIC promoter occu-
pancy of Pea3 group genes in lung by chromatin immunoprecip-
itation (ChIP) using anti-CIC antibodies followed by PCR of the
promoter regions containing CIC binding motifs (Figures 4A
and 4B). We found that CIC is indeed bound to the promoters
of Pea3 group genes in lung cells (Figure 4B). Next, we checked
the levels of Pea3 group genes in lung tissues from 6-day-old
WT, Atxn1/, and Atxn1L/ mice by qRT-PCR. The levels of
Etv1 and Etv4 were significantly upregulated in Atxn1L/
mice, whereas Atxn1/mice did not have significant alterations
in the levels of these three genes (Figure 4C), suggesting that
ATXN1L plays a more important role than ATXN1 in regulation
of Pea3 group gene expression and consistent with the predom-
inant effect of ATXN1L deficiency on destabilization of CIC (Fig-
ure 3E). An increase in ETV4 protein levels inAtxn1L/mice was
* *
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Figure 5. Derepression of Etv4 Upregulates
MMP9 Levels in Alveolar Macrophage Cells
(A) Western blot image showing a decrease in
MMP9 levels upon knockdown of Etv4 in MH-S
cells.
(B) QRT-PCR analysis for changes in Etv4 levels
upon treatment of MH-S cells with four different
combinations of siRNAs (negative control, Cic and
Etv4). Three independent experiments were
carried out. *p < 0.05 and **p < 0.01. All error bars
show SEM.
(C) Representative western blot image for changes
in MMP9 and CIC levels upon treatment of MH-S
cells with four different combinations of siRNAs
(negative control, Cic, and Etv4).
(D) Quantitative analysis of CIC and MMP9 levels
based on Western blot images from (C). Three
independent experiments were carried out. *p <
0.05 and **p < 0.01. All error bars show SEM.
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Role of ATXN1 and ATXN1L in ECM Remodelingalso confirmed by western blot analysis (Figure 4D). We then
compared the levels of Pea3 group genes among Atxn1 and
Atxn1L double mutants. The levels of Pea3 group genes were
most dramatically and significantly upregulated in the double
null embryos at E18.5 (Figure 4E). Moreover, the levels of Pea3
group genes were inversely correlated with the levels of CIC
proteins, demonstrating that mice with the most significant
reduction in CIC levels had the highest fold change in Pea3
group gene expression (Figures 3C and 4E). These data
provide further support to the idea that the loss of ATXN1/
ATXN1L leads to derepression of CIC target genes due to desta-
bilization of CIC.
Derepression ofEtv4 IncreasesMMP9Levels in Alveolar
Macrophages
Previous reports demonstrated that ETV4 activates transcription
ofMMP9 in various cancer cell lines (Hida et al., 1997; Qin et al.,
2008). Enhanced expression of MMP9 has been observed in
alveolar macrophages from chronic obstructive pulmonary
disease (COPD) patients (Finlay et al., 1997). Furthermore,
transgenic overexpression of MMP9 in alveolar macrophages
causes emphysema in mice and is associated with the loss of
alveolar elastin (Foronjy et al., 2008). Therefore, we hypothe-
sized that increased levels of ETV4 may lead to the overexpres-
sion of MMP9 in either Atxn1L/ or Cic-L/ mice. To test this
hypothesis, we first investigated whether ETV4 regulates
expression of MMP9 in mouse alveolar macrophage cell line
(MH-S) by knocking down Etv4. The levels of MMP9 are reduced
upon treatment with two different siRNAs against Etv4 in MH-S
cells, suggesting that ETV4 indeed regulates expression ofDevelopmental Cell 21, 746–757,MMP9 in alveolar macrophages (Fig-
ure 5A). However, knocking down ETV4
did not change the levels of MMP9 in
immortalized lung epithelial cells (A549)
(Figure S4), suggesting that regulation of
MMP9 expression by ETV4 might be
cell type-specific. Next, we treated
MH-S cells with siRNAs against Cic to
examine whether knocking down Cic up-regulates the levels of MMP9 and Etv4. Expression of both
MMP9 and Etv4 is indeed highly induced in the cells treated
with Cic siRNAs compared with the cells treated with negative
control siRNAs (Figures 5B–5D). Finally, we transfected Etv4
siRNAs in cells with reduced CIC. The addition of Etv4 siRNAs
rescued the levels of both Etv4 and MMP9 to almost normal
levels without affecting CIC knockdown efficiency, suggesting
that loss of CIC mediates overexpression of MMP9 in alveolar
macrophages by derepression of Etv4 (Figures 5B–5D).
DISCUSSION
In this study, we set out to understand the in vivo function of the
ATXN1 protein family by generating and characterizing both
Atxn1L/ and Atxn1/; Atxn1L/ mutant animals. We uncov-
ered several developmental deficits potentially caused bymisre-
gulation of ECM remodeling in the mutant mice. These
phenotypes appear to be caused by a deficiency of ATXN1/
ATXN1L-CIC complexes because we found that stability of
CIC proteins relies on both ATXN1 and ATXN1L and that
Cic-L/ mice have the same developmental abnormalities
found in the Atxn1 and Atxn1L double mutant animals. As
a consequence, loss of ATXN1/ATXN1L-CIC complexes dere-
presses CIC target genes including Pea3 group genes, leading
to overexpression of MMPs and defects in ECM remodeling.
Functional Redundancy and Differences between
ATXN1 and ATXN1L
Given that ATXN1 and ATXN1L share conserved domains and
several interactors and that their expression profiles are veryOctober 18, 2011 ª2011 Elsevier Inc. 753
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Role of ATXN1 and ATXN1L in ECM Remodelingsimilar (Mizutani et al., 2005), we hypothesized that functional
redundancy of ATXN1L might compensate for the deficiency of
ATXN1 function in Atxn1 null mice. Loss of both ATXN1 and
ATXN1L results in early perinatal lethality and several develop-
mental abnormalities during embryogenesis. Moreover,
a complete removal of Atxn1 from Atxn1L null mice augments
the incidence and severity of the phenotypes in Atxn1L null
mice, suggesting that ATXN1 partially compensates for the
loss of ATXN1L function. Interestingly, our data consistently
show that ATXN1L is more critical than ATXN1 in the manifesta-
tion of all the phenotypes. This phenomenon seems to be closely
associated with the dominant role of ATXN1L in stabilization of
CIC and raises the question of how this occurs. One simple
explanation is that the absolute number of ATXN1L molecules
might be much greater than that of ATXN1 such that ATXN1L-
CIC complexes predominate in most cells. Another explanation
is that CIC may prefer ATXN1L, rather than ATXN1, as a binding
partner. In this case, it would be important to do an in-depth
comparative structural analysis between ATXN1 and ATXN1L,
especially for the AXH domain that is responsible for the interac-
tion of ATXN1 with CIC (Lam et al., 2006). Overall, the data in this
study show that ATXN1 and ATXN1L are functionally redundant
and that ATXN1L plays a pivotal role in development.
ATXN1 Protein Family Regulates ECM Remodeling
In Vivo
Our data showed that loss of ATXN1L causes the lung alveolari-
zation defect associated with overexpression ofMmp genes and
reduction in elastic fibril formation within alveolar walls. Many
genetic studies of mice that are defective in regulation of ECM
remodeling have pointed to the pivotal role of the ECM remodel-
ing in lung alveolarization. Transgenic overexpression of either
MMP1 or MMP9 in lungs leads to progressive adult-onset (at
around 4–6 months after birth) emphysema, whereas mice lack-
ing Timp3 spontaneously develop enlarged air spaces in the lung
at 2 weeks after birth, with disease severity progressing with age
(Foronjy et al., 2003, 2008; Leco et al., 2001). These studies not
only suggest that a tight regulation of MMP activity is critical for
normal lung development, but also indicate that hyperactivation
of multiple MMP enzymes causes an earlier onset of lung alveo-
larization defects rather than the overexpression of a singleMMP
gene. We found that Atxn1L null mice have increased levels for
Mmp genes (Mmp8, Mmp9, Mmp12, and Mmp13) in the lung
at P6 and develop the alveolarization defect leading to enlarged
air spaces at late alveolar stages (P17–P23). Comparing our find-
ings with the previous reports, increased levels ofMmp8,Mmp9,
Mmp12, andMmp13might cooperatively contribute to the onset
of lung alveolarization defects in Atxn1L/ mice.
It is interesting that the Atxn1 and Atxn1L double mutant mice
have other phenotypes, which are also reminiscent of defects in
ECM formation. Hydrocephalus is caused by obstruction in
circulation of cerebrospinal fluid (CSF) leading to accumulation
of CSF and expansion of ventricles in brain. The ECM composi-
tion in the meninges, where the arachnoid villi are located, is re-
garded as an important environment for absorption of CSF into
arachnoid villi (Zhao et al., 2010). Several studies using geneti-
cally engineered mouse models have indicated that alterations
in MMP9 levels are associated with development of hydroceph-
alus (Zechel et al., 2002; Mun˜oz et al., 2006; Oshima et al., 1996).754 Developmental Cell 21, 746–757, October 18, 2011 ª2011 ElsevTherefore, our finding that MMP9 levels are upregulated in the
meninges from Atxn1L/ mice may explain the onset of hydro-
cephalus in Atxn1L/mice. Abdominal wall hernias are consid-
ered a disease of the ECM because disturbances in collagen
metabolism are strongly associated with these developmental
defects in humans (Antoniou et al., 2009). Several clinical studies
have shown thatMMP1,MMP2,MMP9, andMMP13 are overex-
pressed in patients with abdominal wall hernias (Antoniou et al.,
2009). In this regard, the omphalocele in Atxn1/; Atxn1L/
double mutant embryos might result from the role of ATXN1
protein family in ECM formation. Taken together, our findings
suggest that the ATXN1 protein family plays a critical role in
ECM remodeling during development.
ATXN1/ATXN1L-CIC Complexes Are Critical for
the Molecular Pathway Regulating ECM Remodeling
In this study, we found that CIC levels are decreased whereas
Pea3 group genes are overexpressed in Atxn1/; Atxn1L/
double mutant animals. We also verified that expression of
Pea3 group genes is regulated by ATXN1/ATXN1L-CIC tran-
scriptional repressor complexes in lung cells. Given that more
than one purine rich PEA3 element (A/CGGAA/T) exists in
promoter regions of most Mmp genes, overexpression of a
subset of Mmp genes in Atxn1L/ mice may be mediated by
derepression of Pea3 group genes. Indeed, we showed that
derepression of Etv4 due to knockdown of Cic mediates the
overexpression of MMP9 in the alveolar macrophage cells. It
has also been shown that ETV4 regulates Mmp13 expression
in hepatic stellate cells (Dı´az-Sanjua´n et al., 2009). Altogether,
our study demonstrates that ATXN1/ATXN1L-CIC complexes
directly regulate the expression of PEA3 group genes, thereby
mediating the regulation of a subset of MMP genes.
Potential Roles of ATXN1/ATXN1L-CIC Complexes
in the Pathogenesis of Disorders Involving ECM
Remodeling
The pathogenesis of many human diseases, such as rheumatoid
arthritis, asthma, arthrosclerosis, hypertension, and fibrosis, is
strongly associated with the misregulation of ECM remodeling
due to alterations in MMP levels. Moreover, in cancer, altered
proteolysis leads to unregulated tumor growth, inflammation,
tissue invasion, and metastasis (Kessenbrock et al., 2010).
Indeed, it is well known that increased expression of MMPs is
associated with cancer cell invasion and migration (Roy et al.,
2009). Additionally, overexpression of PEA3 group genes have
been found in many different human tumors including breast
cancer, nonsmall cell lung carcinoma, and leukemia (Kurpios
et al., 2003). Given the critical roles of MMPs and PEA3 group
proteins in tumorigenesis and cancer metastasis, our data
suggest that the ATXN1/ATXN1L-CIC complex might potentially
affect tumorigenesis or cancer metastasis. Intriguingly, one
frameshift and three missense mutations in the CIC gene have
been identified in patients with breast cancer and lung cancer
cells (Sjo¨blom et al., 2006; Kan et al., 2010). Recently, mutations
in CIC gene were found in tumor tissue from patients with oligo-
dendrogliomas (OD), the second most common malignant brain
tumor in adults (Bettegowda et al., 2011). Moreover, analysis on
the expression profiles of ATXN1, ATXN1L, and CIC in various
cancer samples using the Oncomine database analysis toolier Inc.
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Role of ATXN1 and ATXN1L in ECM Remodeling(http://www.oncomine.org/) reveals that the levels of all three
genes are significantly downregulated in breast and brain cancer
patients (data not shown), suggesting that loss of ATXN1/
ATXN1L-CIC functions might contribute to tumorigenesis of
particular types of cancer. In sum, this study reveals that
ATXN1 protein family, together with CIC, is critical for develop-
ment and for regulating key steps in transcriptional control of
ECM remodeling. Moreover, these findings raise the interesting
possibility about a potential role of these proteins in the patho-
genesis of many human diseases associated with defects in
ECM remodeling.
EXPERIMENTAL PROCEDURES
Generation of Atxn1L Knockout Mice
Generation of Atxn1L knockout mice was carried out using a targeting
construct previously used to generate a duplication allele (Bowman et al.,
2007). To generate a replacement vector, the targeting construct was linear-
ized using SfiI. Identification of targeted cells and generation of chimeras
and Atxn1L+/mice were done as previously described (Bowman et al., 2007).
Mouse Mating
To test viability of mutant mice at P21 (Table 1), we mated mice using
the following combinations: Atxn1+/; Atxn1L+/ and Atxn1+/; Atxn1L+/,
Atxn1+/; Atxn1L+/ and Atxn1/; Atxn1L+/, or Atxn1+/; Atxn1L+/ and
Atxn1+/; Atxn1L/. To investigate the omphalocele at E18.5-E19 (Table 1),
we obtained the embryos from crosses between Atxn1+/; Atxn1L+/ and
Atxn1+/; Atxn1L+/,Atxn1+/; Atxn1L+/ andAtxn1/; Atxn1L+/, orAtxn1+/;
Atxn1L+/ and Atxn1+/; Atxn1L/.
Histology
Brain and lung tissues were dissected and fixed with 10% formalin (Sigma) at
4Covernight. The lungs frommice older than 3weekswere pressure perfused
at 20 cm H2O with 10% formalin at 4
C overnight. Tissues were dehydrated
gradually by 70% to 100% EtOH, equilibrated with chloroform overnight,
embedded in paraffin blocks, and sectioned at 6 mm thickness. Sections
mounted onto slides were stained with H&E for histological analysis. Lungs
from more than twenty 2.5- to 3.5-week-old Atxn1L/ and four 2- to
3-week-old Cic-L/ mice were analyzed with H&E staining. For Verhoeff
staining, ACCUSTAIN Elastic Stain kit (Sigma) was used according to manu-
facturer’s instruction. The step for staining in VanGieson solutionwas skipped.
Measurement of the Empty Space Area in E17.5 Embryonic Lung
Tissue Sections
Four 103 images were captured from H&E-stained lung tissue sections from
E17.5 double heterozygous and double null embryos. Each image was con-
verted into 8 bit binary image with ImageJ software. The empty space area
was determined by calculating the number of white pixels using ImageJ soft-
ware and then divided by the number of pixels for whole image area to get the
percentage of empty space area in the lung sections.
Immunohistochemistry
The lung tissues embedded in paraffin blocks were sectioned at 6 mm thick-
ness and subjected to the immunohistochemistry using rabbit polyclonal
antibodies for CCSP (Abcam, 1:2000) and SFTPC (Millipore, 1:5000). The
VECTASTATIN Elite ABC kit (Vector Lab) was used for the immunohistochem-
istry according to the manufacturer’s instruction.
Morphometric Analysis
Measurement of mean linear intercept (MLI) was conducted as described
previously with some modification (Robbesom et al., 2003). Sixteen 403
images were randomly captured from H&E-stained lung tissue sections from
2.5- to 3-week-old WT, Atxn1L/, and Atxn1+/; Atxn1L/ mice and
analyzed for the MLI. Total number of counted intercepts was about 900 per
each genotype.DevelopmCounting the Number of Alveolar Macrophage Cells
Bronchoalveolar lavage (BAL) fluid collection and quantitation of airway alve-
olar macrophage cells were carried out as previously described (Kheradmand
et al., 2002). BAL cells were collected by serially instilling and withdrawing
0.7 ml aliquots of PBS from the tracheal cannula. After cells were washed
and enumerated, aliquots of 105 cells were centrifuged onto glass slides,
stained using modified Giemsa, and used to determine the absolute numbers
of alveolar macrophage cells.
Determination of the Elastin Content in the Alveolar Walls
Measurement of alveolar wall elastin content was conducted as described
previously with some modification (Foronjy et al., 2008). Five 403 images
were captured from Verhoeff-stained lung tissue sections from 7- to
9-month-old WT and Atxn1L/ mice (n = 4 in each genotype). Each 403
image was magnified four times to make the stained elastic fibrils easily
discernible, and then analyzed for both the whole alveolar wall area and elastic
fibrils-occupying area within alveolar walls using ImageJ software. The
average elastin percent area for each genotype was calculated as described
previously (Foronjy et al., 2008).
Microarray Analysis
One hundred nanograms of lung total RNA from either 6 day-oldWT,Atxn1/,
or Atxn1L/ mice (three pairs of WT and Atxn1/ mice and four pairs of WT
and Atxn1L/mice) was used for microarray analysis using Affymetrix Mouse
Gene 1.0 ST Array. The data were analyzed using Limma package in the
Bioconductor R (http://www.bioconductor.org/). The signal intensities were
obtained and corrected for background by using robust multi-array analysis
(RMA) algorithm (Irizarry et al., 2003). Probes having low signal intensity
(<90) were excluded from the analysis to reduce the inconsistency associated
with low-intensity signals. p values were calculated with a modified t test in
conjunction with empirical Bayes method (Smyth, 2004). Probes with fold-
change >1.2 and p values < 0.05 were considered to be differentially
expressed. The Gene Expression Omnibus (GEO) accession number of micro-
array data is GSE29551.
Western Blot Analysis
Tissues were dissected from mice at either E18.5, P6, or P20 and frozen
quickly in liquid nitrogen. In case of lung tissues, the right four lobules were
dissected and chopped into several small pieces in cold phosphate buffered
saline (PBS) and large blood vessels were removed under dissecting micro-
scope before frozen in liquid nitrogen. The tissues were sonicated in RIPA
buffer (150 mM NaCl, 50 mM Tris-HCl pH 8.0, 2 mM EDTA pH 8.0, 1% Triton
X-100, 0.5% deoxychloric acid, 0.1% SDS) with protease and phosphatase
inhibitors and incubated on ice for 15 min. After centrifugation at 13,200 rpm
for 15 min, the supernatant was taken and 20 mg of that was used for sample
preparation. The protein samples were loaded on NuPage 4%–20% Bis-Tris
gel (Invitrogen) and transferred to Trans-Blot nitrocellulose membrane
(Bio-Rad). Primary antibodies for CIC, ATXN1 (11750), and ATXN1L were
used as described previously (Bowman et al., 2007). Rabbit polyclonal anti-
MMP9 (Abcam) and anti-ETV4 (ProteinTech Group) antibodies were used at
1:1000 and 1:500 dilutions, respectively.
Gelatin Zymography
Twenty micrograms of protein extract from P6 lung or meningeal tissues was
loaded on Novex 10% Zymogram (Gelatin) gel (Invitrogen). After electropho-
resis, developing and staining the gel were carried out according to the manu-
facturer’s manual (Invitrogen).
RNAi
MH-S and A549 cells were cultured in RPMI 1640 media (Invitrogen) supple-
mented with 10% FBS. They were plated the day before transfection at about
50% confluence in 6cm dishes. The following day, the indicated amount of
siRNAs for negative control, CIC, ETV4 (mouse), and ETV4 (human) was trans-
fected using DharmaFECT I transfection reagent (Dharmacon) according to
the manufacturer’s protocol. Three to four days later, cells were harvested.
Protein samples for western blot analysis were prepared by lysis of the cells
in cold RIPA buffer for 15 min followed by centrifugation at 13,000 rpm for
15 min. Total RNA was extracted using Trizol (Invitrogen) and subjected toental Cell 21, 746–757, October 18, 2011 ª2011 Elsevier Inc. 755
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Dharmacon, mouse Etv4 stealth siRNAs from Invitrogen, and human ETV4
siRNAs from Ambion). The target sequences of siCIC are 50-GGUGCAACAAG
GACCGAAA-30. The target sequences of siETV4-1 and siETV4-2 are 50-CCUU
CUGCAGCAAAUCUCCCGGAAA-30 and 50-AGAAGCUCAGGUACCGGACA
GUGAU-30, respectively. The target sequences of siETV4-1 and siETV4-2
are 50-GGACUUCGCCUACGACUCA-30 and 50-CCUGAUUUCCAUUCAGA
AA-30, respectively.QRT-PCR
Two to three micrograms of total RNA from lung tissues, MH-S, or A549 cells
was used for cDNA synthesis using M-MLV-RT (Invitrogen). Quantitative RT-
PCR was carried out using commercially available or homemade primers and
probes for studied genes. For Etv1, 50-GACCAGCAAGTGCCTTACGT-30
(Forward), 50-GACATTTGTTGGTTTCTCGGTACA-30 (Reverse), and 50-TCAC
CAACAGTCAGCGTGGGAGAAA-30 (Probe) were used. For Etv4, 50-CACTC
CCCTACCACCATGGA-30 (Forward), 50-GGACTTGATGGCGATTTGTC-30
(Reverse), and 50-AGCAGTGCCTTTACTCCAGTGCCTATGA-30 (Probe) were
used. For Etv5, 50-GATTGACAGAAAGAGGAAGTTTGTG-30 (Forward), 50-GC
AGCTGGCTAAGATCCTGAA-30 (Reverse), and 50-CAGATCTGGCTCACGATT
CTGAAGAGTTG-30 (Probe) were used. TaqMan gene expression assays
(Applied Biosystem) were used for detection of Mmp2 (Mm00439506_m1),
Mmp3 (Mm00440295_m1), Mmp8 (Mm00772335_m1), Mmp9 (Mm
00442991_m1), Mmp11 (Mm00485048_m1), Mmp12 (Mm00500554_m1),
Mmp13 (Mm01168713_m1), Mmp14 (Mm01318966_m1), Timp1 (Mm
00441818_m1), Timp2 (Mm00441825_m1), and Timp3 (Mm00441826_m1). For
Gapdh, TaqMan rodent GAPDH control reagent (Applied Biosystem) was used.
The SYBR Green was used for detection of PCR amplification of human ETV4,
MMP9, and GAPDH genes. The primer sequences for ETV4 are 50-GCA
GTTTGTTCCTGATTTCCA-30 (Forward) and 50-ACTCTGGGGCTCCTTCTTG-30
(Reverse). The primer sequences for MMP9 are 50-TCTTCCCTGGAGACCT
GAGA-30 (Forward) and 50-GAGTGTAACCATAGCGGTACAGG-30 (Reverse).
The primer sequences for GAPDH are 50-AGCCACATCGCTCAGACAC-30
(Forward) and 50-GCCCAATACGACCAAATCC-30 (Reverse).Chromatin Immunoprecipitation and PCR for Mouse Pea3 Group
Gene Promoters
Chromatin immunoprecipitation (ChIP) was carried out as previously
described (Chahrour et al., 2008) with some modifications. In this experiment,
P6 lung tissues and rabbit polyclonal anti-CIC antibody (Abcam) were used. To
detect association of CIC with Etv1, Etv4, and Etv5 promoters, the following
primers were used for PCR. For Etv1 promoter, 50-GAGGAACTTGGG
CCTTTGTTATG-30 (Forward) and 50-TGCTTTCGAGCAGGGGGC-30 (Reverse)
were used for PCR. For Etv4 promoter, 50-CGTGGAGAAGCTGCCGGGTC-30
(Forward) and 50-CTCCCCACCGGTTCCCTTTG-30 (Reverse) were used for
PCR. For Etv5 promoter, 50-GGTGCAGGCCGAGGCCAGGG-30 (Forward)
and 50-CATTGACCAATCAGCACCGG-30 (Reverse) were used for PCR.Statistical Analyses
For statistical analysis, all experiments were carried out more than three times
independently. The western blots were quantified using ImageJ software
package. Statistical significance between control values and experimental
values was determined using Student’s t test (two-tailed, two-sample unequal
variance). Statistical significance is represented with asterisks.ACCESSION NUMBERS
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